These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1498964

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological treatment of behavioural and psychological symptoms of dementia in psychogeriatric inpatient units.
    Restifo S, Lemon V, Waters F.
    Australas Psychiatry; 2011 Feb; 19(1):59-63. PubMed ID: 21189108
    [Abstract] [Full Text] [Related]

  • 8. Delusions in dementia: a review.
    Flint AJ.
    J Neuropsychiatry Clin Neurosci; 1991 Feb; 3(2):121-30. PubMed ID: 1687962
    [Abstract] [Full Text] [Related]

  • 9. Memantine in the treatment of dementia.
    Maggiore C, Locatelli L, Grandi FC, Pizzolato G, Cochrane Neurological Network.
    Neuroepidemiology; 2007 Feb; 28(2):118-9. PubMed ID: 17409774
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
    Desmidt T, Hommet C, Camus V.
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep 01; 14(3):300-6. PubMed ID: 27651011
    [Abstract] [Full Text] [Related]

  • 11. [Psychopharmacotherapy of behavioral disorders in patients with dementia].
    Stoppe G, Staedt J.
    Z Gerontol Geriatr; 1999 Jun 01; 32(3):153-8. PubMed ID: 10436494
    [Abstract] [Full Text] [Related]

  • 12. Meta-analysis of controlled pharmacologic trials.
    Schneider LS.
    Int Psychogeriatr; 1996 Jun 01; 8 Suppl 3():375-9; discussion 381-2. PubMed ID: 9154592
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Frontotemporal dementias: clinical features and management.
    Chow TW.
    Semin Clin Neuropsychiatry; 2003 Jan 01; 8(1):58-70. PubMed ID: 12567333
    [Abstract] [Full Text] [Related]

  • 15. Neuropsychiatric symptoms and psychotropic drug use in patients with dementia in general practices.
    Borsje P, Lucassen PLBJ, Wetzels RB, Pot AM, Koopmans RTCM.
    Fam Pract; 2018 Jan 16; 35(1):22-28. PubMed ID: 28985387
    [Abstract] [Full Text] [Related]

  • 16. Amitriptyline in Alzheimer's disease.
    Reding MJ, Young R, DiPonte P.
    Neurology; 1983 Apr 16; 33(4):522-3. PubMed ID: 6682203
    [No Abstract] [Full Text] [Related]

  • 17. Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam.
    Claus JJ, Ludwig C, Mohr E, Giuffra M, Blin J, Chase TN.
    Neurology; 1991 Apr 16; 41(4):570-4. PubMed ID: 2011259
    [Abstract] [Full Text] [Related]

  • 18. Prescribing pattern of psychotropic drugs in nursing home residents with dementia.
    Wetzels RB, Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT.
    Int Psychogeriatr; 2011 Oct 16; 23(8):1249-59. PubMed ID: 21682938
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic lying to assist people with dementia in maintaining medication adherence.
    Mitchell G.
    Nurs Ethics; 2014 Nov 16; 21(7):844-5. PubMed ID: 25355415
    [No Abstract] [Full Text] [Related]

  • 20. Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?
    Lavretsky H.
    Am J Geriatr Psychiatry; 2008 Jul 16; 16(7):523-7. PubMed ID: 18591572
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.